Literature DB >> 18642885

Acidic residues C-terminal to the A2 domain facilitate thrombin-catalyzed activation of factor VIII.

Jennifer L Newell1, Philip J Fay.   

Abstract

Factor VIII is activated by thrombin through proteolysis at Arg740, Arg372, and Arg1689. One region implicated in this exosite-dependent interaction is the factor VIII a2 segment (residues 711-740) separating the A2 and B domains. Residues 717-725 (DYYEDSYED) within this region consist of five acidic residues and three sulfo-Tyr residues, thus representing a high density of negative charge potential. The contributions of these residues to thrombin-catalyzed activation of factor VIII were assessed following mutagenesis of acidic residues to Ala or Tyr residues to Phe and expression and purification of the B-domainless proteins from stable-expressing cell lines. All mutations showed reduced specific activity from approximately 30% to approximately 70% of the wild-type value. While replacement of the Tyr residues showed little, if any, effect on rates of thrombin-catalyzed proteolysis of factor VIII and consequent activation, the acidic to Ala mutations Glu720Ala, Asp721Ala, Glu724Ala, and Asp725Ala showed decreased rates of proteolysis at each of the three P1 residues. Mutations at residues Glu724 and Asp725 were most affected with double mutations at these sites showing approximately 10-fold and approximately 30-fold reduced rates of cleavage at Arg372 and Arg1689, respectively. Factor VIII activation profiles paralleled the results assessing rates of proteolysis. Kinetic analyses revealed these mutations minimally affected apparent V max for thrombin-catalyzed cleavage but variably increased the K m for procofactor up to 7-fold, suggesting the latter parameter was dominant in reducing catalytic efficiency. These results suggest that residues Glu720, Asp721, Glu724, and Asp725 likely constitute an exosite-interactive region in factor VIII facilitating cleavages for procofactor activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642885      PMCID: PMC2600807          DOI: 10.1021/bi8007824

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Characterization of tyrosine sulfate residues in antihemophilic recombinant factor VIII by liquid chromatography electrospray ionization tandem mass spectrometry and amino acid analysis.

Authors:  J C Severs; M Carnine; H Eguizabal; K K Mock
Journal:  Rapid Commun Mass Spectrom       Date:  1999       Impact factor: 2.419

2.  Subunit structure and function of porcine factor Xa-activated factor VIII.

Authors:  E T Parker; J Pohl; M N Blackburn; P Lollar
Journal:  Biochemistry       Date:  1997-08-05       Impact factor: 3.162

3.  Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments.

Authors:  K R Dharmawardana; S T Olson; P E Bock
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

4.  The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4.

Authors:  G Kemball-Cook; E G Tuddenham; A I Wacey
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

5.  Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain.

Authors:  Keiji Nogami; Qian Zhou; Timothy Myles; Lawrence L K Leung; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2005-03-03       Impact factor: 5.157

6.  Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.

Authors:  M J Donath; P J Lenting; J A Van Mourik; K Mertens
Journal:  Eur J Biochem       Date:  1996-09-01

7.  Structural requirements for expression of factor Va activity.

Authors:  Michael Kalafatis; Daniel O Beck; Kenneth G Mann
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

8.  Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.

Authors:  P Vincent Jenkins; Jan Freas; Kyla M Schmidt; Qian Zhou; Philip J Fay
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.

Authors:  Jennifer L Newell; Philip J Fay
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

10.  Structural requirements for the activation of human factor VIII by thrombin.

Authors:  Timothy Myles; Thomas H Yun; Lawrence L K Leung
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

View more
  5 in total

1.  Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  J Coagul Disord       Date:  2010-07-01

2.  Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.

Authors:  María Ángeles Corral-Rodríguez; Paul E Bock; Erick Hernández-Carvajal; Ricardo Gutiérrez-Gallego; Pablo Fuentes-Prior
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

3.  Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.

Authors:  Divi Venkateswarlu
Journal:  BMC Struct Biol       Date:  2010-02-25

Review 4.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

Review 5.  Turoctocog alfa (NovoEight®)--from design to clinical proof of concept.

Authors:  Mirella Ezban; Knud Vad; Marianne Kjalke
Journal:  Eur J Haematol       Date:  2014-05-28       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.